FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


14853 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Naproxen 200mg/pseudoephedrine 120mg m/r tablet Product containing only naproxen and pseudoephedrine (medicinal product)
Naproxen 200mg/pseudoephedrine 120mg prolonged-release oral tablet Product containing only naproxen and pseudoephedrine (medicinal product)
Naproxen 500mg m/r tablet Product containing precisely naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug)
Naproxen sodium 220mg/pseudoephedrine 120mg m/r tablet Product containing only naproxen and pseudoephedrine (medicinal product)
Naproxen sodium 220mg/pseudoephedrine 120mg prolonged-release oral tablet Product containing only naproxen and pseudoephedrine (medicinal product)
Naproxen sodium 375mg gastro-resistant oral tablet Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug)
Naproxen sodium 375mg m/r tablet Product containing precisely naproxen 375 milligram/1 each gastro-resistant oral tablet (clinical drug)
Naproxen sodium 500mg gastro-resistant oral tablet Naproxen only product in oral dose form
Naproxen sodium 500mg m/r tablet Naproxen only product in oral dose form
Narrow open angle Narrow angle (finding)
Nasal cavity and ethmoid sinus TNM finding American Joint Committee on Cancer allowable value
Nasal diagnostic laryngoscopy Nasal laryngoscopy
Nasal flap Flap (substance)
Nasalis flap Flap (substance)
Nasolabial flap Flap (substance)
Nasopharyngoscopy: [diagnostic NEC] or [NEC] Nasopharyngoscopy
Nasopharynx TNM finding American Joint Committee on Cancer allowable value
Nausea Nausea (finding)
Near complete invasion of mesorectum by tumor Mesorectal specimen nearly completely intact (finding)
Neck of other metacarpal Neck of metacarpal bone structure (body structure)
Neer 2 part fracture Neer two-part fracture
Neer 3 part fracture Neer three-part fracture
Neer 4 part fracture Neer four-part fracture
Negroid nose Nose finding
Neisseria meningitidis group Z' Neisseria meningitidis serogroup Z (organism)
Neomycin sulfate 0.5% conventional release eye drops Product containing only neomycin in ocular dose form (medicinal product form)
Neomycin sulfate 0.5% single-use eye drops Product containing only neomycin in ocular dose form (medicinal product form)
allergie au sulfate de néomycine Allergy to neomycin (finding)
Neomycin+hydrocortisone 0.5%/1.5% ear drops Hydrocortisone 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL ear solution
Neonatal calf diarrhea coronavirus Bovine coronavirus (organism)
Neonatal candida infection Neonatal candidiasis (disorder)
Neonatal candidiasis of mouth Neonatal candidiasis (disorder)
Neonatal hyperbilirubinemia caused by drugs and/or toxins given to the newborn Neonatal hyperbilirubinemia
Neonatal intestinal perforation co-occurrent and due to congenital intestinal stenosis Neonatal perforation of intestine due to congenital stenosis of intestine
Neonatal monilia infection Neonatal candidiasis (disorder)
Neonatal thrombocytopenia due to isoimmunization Transient neonatal thrombocytopenia
Neophema bourkii Neopsephotus bourkii (organism)
néoplasme selon la localisation corporelle Neoplastic disease
Neoplasm of ill-defined site Neoplastic disease
Neoplasm of perivascular myoid type - category Perivascular myoid neoplasm (morphologic abnormality)
Neoplasm of uncertain behavior of connective and soft tissue Neoplasm of uncertain behavior of soft tissues
Neoplastic process Neoplasm
Neotran Bis-(p-chlorophenoxy) methane
Neovascularization of iris AND/OR ciliary body Disorder of uveal tract
Nephrogenic diabetes insipidus Nephrogenic diabetes insipidus
Nephrolithiasis Kidney stone
Nerve bundle Central nervous system tract structure
Nerve conduction deafness Neural hearing loss
Nerve sheath tumor, no International Classification of Diseases for Oncology subtype Benign nerve sheath tumor
Nervous structure of thorax Structure of peripheral nerve of thorax
Nesochen sandvicensis Branta sandvicensis (organism)
Nettle rash Urticaria
Neuralgia Neuralgia
Neurinomatosis Melanotic schwannoma
Neurocutaneous melanosis sequence Neurocutaneous melanosis
Neuroectodermal endocrine syndrome Woodhouse Sakati syndrome
Neurofibramatosis 3 Schwannomatosis
Neurofibroma, no International Classification of Diseases for Oncology subtype Benign neurofibroma
Neurofibromatosis type 3 Schwannomatosis
Neuroleptic malignant syndrome Neuroleptic malignant syndrome
Neurologic myelopathy-retired Spinal cord disorder (disorder)
Neurological disorder caused by ingestible alcohol Neurological disorder caused by ethanol (disorder)
Neurological status not worse than preoperative baseline Neurological status is consistent with or improved from preoperative baseline (finding)
Neurolysis - action Destruction - action
Neuroma (excl. acoustic) Neuroma (disorder)
Neuroma (excluding acoustic) Neuroma (morphologic abnormality)
Neuroma - category Neuroma (morphologic abnormality)
Neuroma, no International Classification of Diseases for Oncology subtype Neuroma (morphologic abnormality)
Neuromuscular diagnostic procedure Neuromuscular procedure
Neuromyositis-retired Polymyositis
Neuropathic impotence Erectile dysfunction due to neuropathy
Neuroses or other mental disorder NOS Mental disorder
Neurotic, personality and other nonpsychotic disorders Mental disorder
Neurovascular island sensory skin flap NEC Neurovascular island sensory skin flap
Neutral epinephrine 0.05% eye drops Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution
Neutral epinephrine 0.1% eye drops Adrenaline 1 mg/mL eye solution
Neutral epinephrine 0.25% eye drops Adrenaline 2.5 mg/mL eye solution
Neutral epinephrine 0.5% eye drops Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution
Neutron Neutron
Nevirapine 50mg/5mL suspension Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
New sexual contact New sexual contact (finding)
Newborn physiological jaundice NOS Newborn physiological jaundice
Nicardipine hydrochloride 60mg m/r capsule Nicardipine only product in oral dose form
Nicardipine hydrochloride 60mg prolonged-release oral capsule Nicardipine only product in oral dose form
Nicardipine m/r capsule Nicardipine only product in oral dose form
Nicotine 10mg inhalator refill pack Nicotine only product
Nicotine 10mg inhalator starter pack Nicotine only product
Nicotine 10mg inhaler Nicotine only product
Nicotine 11mg/24hours patch Nicotine 458 microgram/hour prolonged-release transdermal patch
Nicotine 22mg/day patch Product containing precisely nicotine 917 microgram/1 hour prolonged-release transdermal patch (clinical drug)
Nicotine dependence with current use Nicotine dependence (disorder)
Nicotine replacement therapy provided free Nicotine replacement therapy
Nicotine replacement therapy provided free Nicotine replacement therapy
Nicotine replacement therapy provided free Nicotine replacement therapy
Nicotine stomatitis Leukokeratosis nicotina palati
Nicotinic acid 375mg m/r tablet and nicotinic acid 500mg m/r tablet and nicotinic acid 750mg m/r tablet starter pack Nicotinic acid only product in oral dose form
Nicotinic acid 375mg prolonged-release oral tablet Nicotinic acid only product in oral dose form
Nifedipine 90mg m/r tablet Product containing only nifedipine in oral dose form (medicinal product form)
Nifedipine 90mg prolonged-release oral tablet Product containing only nifedipine in oral dose form (medicinal product form)
nimodipine 200 microgrammes/mL, fiole de 50 mL pour perfusion Product containing precisely nimodipine 200 microgram/1 milliliter conventional release solution for injection (clinical drug)
Nisoldipine 40mg m/r tablet Nisoldipine only product in oral dose form

Start Previous Page 77 of 149 Next End


Reference Sets

Reference set descriptor

Back to Start